ReviewCancers2022
IRE1α Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies.
Wojciech Wiese et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it
ReviewCancers2022
Wojciech Wiese et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.